HK1089211A1 - Predicting graft rejection - Google Patents

Predicting graft rejection

Info

Publication number
HK1089211A1
HK1089211A1 HK06106235.6A HK06106235A HK1089211A1 HK 1089211 A1 HK1089211 A1 HK 1089211A1 HK 06106235 A HK06106235 A HK 06106235A HK 1089211 A1 HK1089211 A1 HK 1089211A1
Authority
HK
Hong Kong
Prior art keywords
graft rejection
predicting graft
predicting
rejection
graft
Prior art date
Application number
HK06106235.6A
Other languages
English (en)
Chinese (zh)
Inventor
Terry B Strom
Towia Libermann
Asher Schachter
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of HK1089211A1 publication Critical patent/HK1089211A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK06106235.6A 2003-02-14 2006-05-29 Predicting graft rejection HK1089211A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44754003P 2003-02-14 2003-02-14
PCT/US2004/004839 WO2004074815A2 (fr) 2003-02-14 2004-02-17 Prediction des rejets de greffe

Publications (1)

Publication Number Publication Date
HK1089211A1 true HK1089211A1 (en) 2006-11-24

Family

ID=32908457

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106235.6A HK1089211A1 (en) 2003-02-14 2006-05-29 Predicting graft rejection

Country Status (6)

Country Link
US (1) US8741557B2 (fr)
EP (1) EP1599602B1 (fr)
AU (1) AU2004213839B2 (fr)
CA (1) CA2516013C (fr)
HK (1) HK1089211A1 (fr)
WO (1) WO2004074815A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20060263813A1 (en) * 2005-05-11 2006-11-23 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
CA2957704A1 (fr) 2004-01-21 2005-08-04 The Board Of Trustees Of The Leland Stanford Junior University Procedes et compositions pour la determination de phenotype a tolerance vis-a-vis du greffon chez un sujet
US8150136B2 (en) * 2004-03-16 2012-04-03 Amnis Corporation Image based quantitation of molecular translocation
EP2604703B1 (fr) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Procédés permettant d'évaluer la survie d'un greffon chez un destinataire d'une transplantation d'organe solide
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2006124827A2 (fr) * 2005-05-13 2006-11-23 University Of Miami Dissection moleculaire de reponses cellulaires a un alloantigene ou un auto-antigene dans un rejet de greffe et une maladie auto-immune
GB0607943D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
DE102006019480A1 (de) * 2006-04-26 2007-10-31 Sirs-Lab Gmbh Verfahren zur in-vitro Überwachung postoperativer Veränderungen nach Lebertransplantation
EP2049713A4 (fr) * 2006-07-21 2010-06-16 Univ Alberta Rejet tissulaire
SE530596C2 (sv) 2006-10-13 2008-07-15 Mathias Karlsson Metod att fastställa syrebrist i blod från skalpen under förlossning
WO2008154525A2 (fr) * 2007-06-07 2008-12-18 Althea Technologies, Inc. Prédiction de l'efficacité de vaccin
WO2009045104A1 (fr) * 2007-10-05 2009-04-09 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Procédé de diagnostic d'un rejet présymptomatique de greffe d'organes
EP2075344A1 (fr) * 2007-12-21 2009-07-01 Gert Mayer Procédé d'analyse de diagnostic
EP2324129A4 (fr) 2008-08-18 2012-06-20 Univ Leland Stanford Junior Procédés et compositions pour déterminer un phénotype tolérant à une greffe chez un sujet
CN106755415A (zh) * 2009-01-15 2017-05-31 小利兰·斯坦福大学托管委员会 用于诊断和预测移植物排斥的生物标志物板
WO2011006119A2 (fr) 2009-07-09 2011-01-13 The Scripps Research Institute Profils d'expression génique associés à une néphropathie chronique de l'allogreffe
WO2011068829A1 (fr) 2009-12-02 2011-06-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarqueurs pour déterminer un xénotype tolérant à l'allogreffe
EP2803735B1 (fr) 2010-03-25 2020-03-25 The Board of Trustees of the Leland Stanford Junior University Biomarqueurs de protéines et de gènes pour le rejet d'organes transplantés
WO2012139051A2 (fr) 2011-04-06 2012-10-11 The Board Of Trustees Of The Leland Stanford Junior University Biomarqueurs d'auto-anticorps pour néphropathie iga
ES2615818T3 (es) 2011-05-27 2017-06-08 Biovialife Inc. Biomarcadores para el pronóstico y diagnóstico in vitro de rechazo de injertos y trasplantes
GB201304460D0 (en) * 2013-03-13 2013-04-24 Univ Leeds Biomarker
EP2884283A1 (fr) * 2013-12-10 2015-06-17 Chu Nantes Procédé pour la prédiction de la reprise fonctionnelle retardée du greffon dans la transplantation de rein
AU2015229270B2 (en) 2014-03-12 2020-12-24 Icahn School Of Medicine At Mount Sinai Method for identifying kidney allograft recipients at risk for chronic injury
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
AU2015279542B2 (en) 2014-06-26 2021-07-29 Icahn School Of Medicine At Mount Sinai Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
JP7464279B2 (ja) 2018-04-16 2024-04-09 アイカーン スクール オブ メディスン アット マウント シナイ レシピエント血液における移植前トランスクリプトームシグネチャーを使用した急性拒絶反応および腎臓同種異系移植喪失の予測のための方法およびキット
TWI709188B (zh) 2018-09-27 2020-11-01 財團法人工業技術研究院 基於機率融合的分類器、分類方法及分類系統
RU2758994C1 (ru) * 2020-12-23 2021-11-08 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТИО им. академика В.И. Шумакова" Минздрава России) Способ диагностики острого отторжения трансплантата у реципиентов трансплантированного сердца
RU2765462C1 (ru) * 2021-06-11 2022-01-31 Федеральное Государственное Бюджетное Учреждение «Российский Научный Центр Радиологии И Хирургических Технологий Имени Академика А.М. Гранова» Министерства Здравоохранения Российской Федерации Способ прогнозирования риска возникновения ранней дисфункции трансплантата трупной печени
WO2023034292A1 (fr) * 2021-08-30 2023-03-09 University Of Maryland, Baltimore Procédés de prédiction du résultat à long terme chez les patients ayant subi une transplantation rénale, à l'aide des transcriptomes rénaux pré-transplantation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO900155L (no) * 1989-01-24 1990-07-25 Molecular Therapeutics Inc Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1.
US6605271B2 (en) 1996-08-23 2003-08-12 Human Genome Sciences, Inc. T1 receptor-like ligand II and uses thereof
AU4964797A (en) 1996-11-15 1998-06-10 Institute Of Cytosignal Research, Inc. Transcription repressor
US20030104371A1 (en) * 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
EP1073739B1 (fr) 1998-04-29 2006-12-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Proteines interagissant avec cd40 et avec traf
AU2001238585A1 (en) * 2000-02-24 2001-09-03 Human Genome Sciences, Inc. Human polynucleotides, polypeptides, and antibodies
US6900015B2 (en) 2000-04-24 2005-05-31 Beth Israel Deaconess Medical Center, Inc. Measurement of protective genes in allograft rejection

Also Published As

Publication number Publication date
WO2004074815A3 (fr) 2005-01-13
US20070122806A1 (en) 2007-05-31
AU2004213839B2 (en) 2010-08-12
CA2516013A1 (fr) 2004-09-02
WO2004074815A2 (fr) 2004-09-02
EP1599602B1 (fr) 2015-01-14
AU2004213839A1 (en) 2004-09-02
EP1599602A2 (fr) 2005-11-30
EP1599602A4 (fr) 2007-02-07
US8741557B2 (en) 2014-06-03
CA2516013C (fr) 2014-05-13

Similar Documents

Publication Publication Date Title
HK1089211A1 (en) Predicting graft rejection
GB2407580B (en) Biomaterial
TWI372050B (en) (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
EP1645164A4 (fr) Aide auditive
EP1677706A4 (fr) Stent amovible
DE602004022294D1 (en) Hexahydropyridoisochinoline als dpp-iv-inhibitoren
EP1708651A4 (fr) Greffe osseuse stabilisee
EP1694250A4 (fr) Endoprothese couverte amovible
GB0402103D0 (en) Tubular graft
DE602004013806D1 (en) Chinazolinderivate als tyrosinkinaseinhibitoren
TW568408U (en) Slide structure
ZA200508286B (en) Partition
GB0311221D0 (en) Biomaterial
AU155161S (en) Case
EP1627979A4 (fr) Charniere coulissante
GB0309397D0 (en) Screening methods
GB0405784D0 (en) Slide member
GB0301686D0 (en) Cage
AU156105S (en) Pan
AU155596S (en) Case
EP1702851A4 (fr) Tiroir a encoche
EP1669446A4 (fr) Methode de criblage
GB2443335B (en) Graft materials
GB2418286B (en) Disk-body sorter
GB0310717D0 (en) Graft retainer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210217